Ani Pharmaceuticals reported $-20130000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Aerie Pharmaceuticals AERI:US $ -19.37M 16.52M
Aurora Cannabis Inc ACB:CN -1012177000 937.4M
Canopy Growth Corp WEED:CN C$ -2083148000 1.51B
Depomed DEPO:US $ 7.83M 1.23M
Eli Lilly And LLY:US $ 952.5M 950.4M
Emergent Biosolutions EBS:US $ -56.4M 52.7M
Endo International Ordinary Shares ENDP:US $ -1885.43M 1813.45M
Hikma Pharmaceutical HIK:LN 173M 0
Knight Therapeutics Inc GUD:CN C$ 2.52M 21.33M
Lannett LCI:US $ -34.9M 46.19M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Novartis NVS:US $ 1694M 528M
Omeros OMER:US $ -30849000 2.16M
Perrigo Ordinary Shares PRGO:US $ -65.1M 62.7M
Sun Pharmaceuticals SUNP:IN IR 20608.8M 43381.3M
Teva Pharmaceutical TEVA:IT -233000000 722M
Teva Pharmaceutical Industries TEVA:US $ -233M 722M